Domenica M Rubino (Domenica Rubino)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Obstructive Sleep Apnea

Top Venues

Diabetes, obesity & metabolism

Postgraduate medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Domenica M Rubino, Jakob Bue Bjorner, Naveen Rathor, Arya M Sharma, Lisa von Huth Smith, Sean Wharton, Thomas A Wadden, Niels Zeuthen, Ronette L Kolotkin
Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials. Diabetes, obesity & metabolism 26 (7) (2024)
Domenica M Rubino, Jakob Bue Bjorner, Naveen Rathor, Arya M Sharma, Lisa von Huth Smith, Sean Wharton, Thomas A Wadden, Niels Zeuthen, Ronette L Kolotkin
Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials. Diabetes, obesity & metabolism (2024)
Domenica M Rubino, Jakob Bue Bjorner, Naveen Rathor, Arya M Sharma, Lisa von Huth Smith, Sean Wharton, Thomas A Wadden, Niels Zeuthen, Ronette L Kolotkin
Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials. Diabetes, obesity & metabolism 26 (7) (2024)
Anders Strathe, Deborah Bade Horn, Malte Selch Larsen, Domenica M Rubino, Rasmus Sørrig, Marie Thi Dao Tran, Sean Wharton, Rune Viig Overgaard
A model-based approach to predict individual weight loss with semaglutide in people with overweight or obesity. Diabetes, obesity & metabolism (2023)
Patrick M O'Neil, Domenica M Rubino
Exploring the wider benefits of semaglutide treatment in obesity: insight from the STEP program. Postgraduate medicine 134 (sup1) (2023)
Sean Wharton, Melanie Jane Davies, Dror Dicker, Ildiko Lingvay, Lawrence A Leiter, Domenica M Rubino, Sue D Pedersen
Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgraduate medicine (2021)